ESC 365 - Anticoagulant therapy in native or operated valvular diseases.

ESC Premium Access

Anticoagulant therapy in native or operated valvular diseases.

Session: What has changed in valvular heart disease between 2001 and 2017? What every cardiologist should know.

Topic: Valvular Heart Disease

Speaker: Professor B. Prendergast (London, GB)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Bernard David Prendergast

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)

21 presentations

8 followers

3 more presentations in this session

Patient presentation.

Speaker: Professor B. Iung (Paris, FR)

Management of aortic stenosis.

Speaker: Professor R. Rosenhek (Vienna, AT)

Management of mitral regurgitation.

Speaker: Doctor V. Delgado (Barcelona, ES)

Access the full session

What has changed in valvular heart disease between 2001 and 2017? What every cardiologist should know.

Speakers: Professor B. Prendergast, Professor B. Iung, Professor R. Rosenhek, Doctor V. Delgado

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources